Tag: intellectual property

WINNIPEG, Manitoba, July 14, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V: KNE) (“Kane Biotech” or “Kane”) announces today that Kane Biotech’s Interim Chief Executive Officer, Dr. Robert Huizinga, will be presenting at the 4^th Advanced Wound Care Summit USA taking place from July 15-17, 2025 in Boston, MA.

Operating expenses reduced 58% YoY and net loss narrowed 43% as Rivalry emerges a lean, high-performance engine built for scale, with Q2 setting new records in key user metrics

Denver, CO, July 14, 2025 (GLOBE NEWSWIRE) -- Against the backdrop of accelerating integration between culture and technology worldwide, BookWorld Media Ltd. is actively expanding its global network of publishing partners through a platform-driven and data-powered strategy. The company is playing a pivotal role in the digital transformation of the publishing industry by fostering intelligent upgrades across the sector. Headquartered in the United States, BookWorld Media Ltd. is redefining traditional publishing and distribution models by creating an efficient global channel that connects content creators, publishers, and international markets.



Since its founding, BookWorld Media Ltd. has focused on the fields of cultural content creation and publishing services, striving to empower the global publishing ecosystem through technological innovation. The company champions the concept of “Intelligent Content + Precision Distribution,” offering end-to-end solutions that integrate content planning, distribution, and performance evaluation—enabled by data mining and AI algorithms.

BookWorld Media Ltd. has established long-term strategic partnerships with publishers across Asia, Europe, the Americas, and other global regions. These collaborations span a wide range of areas, including traditional print publishing, digital publishing, and the development of interactive content. Leveraging its proprietary intelligent distribution system, the company provides multilingual, multi-platform, and multi-device content delivery services, significantly enhancing the global dissemination efficiency of publishing content.

A company spokesperson stated: “We are building a globally-oriented, technology-backed infrastructure for publishing content. Our goal is not only to help publishers extend their global reach but also to offer content creators more valuable distribution channels and data feedback systems.”

In addition to technological platform development, BookWorld Media Ltd. is placing strong emphasis on partnerships with international copyright organizations to ensure lawful content circulation and compliance with intellectual property regulations. The company also supports publishing partners in managing cross-border copyright matters, thereby strengthening the sustainability of their international operations. A dedicated client support team is available to provide customized content operations assistance and in-depth data analysis reports, helping publishers refine editorial direction and optimize marketing strategies.

BookWorld Media Ltd. is also pursuing innovation in marketing and content promotion. The company’s intelligent recommendation engine automatically matches content with target audiences based on user behavior and interest profiles, enabling more precise outreach. The platform regularly generates key performance insights—including audience segmentation, content conversion rates, and regional engagement trends—empowering partners to adapt marketing strategies in real time and improve campaign performance.

As global demand for diverse cultural content continues to grow, BookWorld Media Ltd. reaffirms its commitment to investing in content technology, platform ecosystem development, and international collaboration. Looking ahead, the company will focus on the publishing potential of emerging markets and explore cross-industry synergies with sectors such as education, film, and short-form video to unlock new cultural value in digital environments.

As an innovation-driven enterprise dedicated to global cultural dissemination, BookWorld Media Ltd. is leveraging the synergy of technology, resources, and strategy to lead the publishing industry into a new era of intelligent globalization.

ROCKVILLE, Md. and SUZHOU, China, July 14, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International Inc. (NASDAQ: AAPG; HKEX: 6855) (“Ascentage” or the “Company”), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, today announced the pricing of 22 million ordinary shares, par value $0.0001 per share, of the Company (the “Placement Shares”), at a price of HKD68.60 per share, in the offering by Dajun Yang Dynasty Trust, an affiliate of the Company’s Chief Executive Officer, Dajun Yang, M.D., Ph.D. (the “Vendor”) in an offshore transaction outside the United States to non-U.S. persons in reliance on Regulation S under the Securities Act of 1933, as amended (the “Securities Act”)(the “Offshore Placement”), for aggregate gross proceeds of approximately HKD1,509.2 million (or approximately US$192.3 million based on exchange rate of 1 USD to 7.85 HKD), before deducting placing fees and other offering expenses. The Offshore Placement, which was oversubscribed by eight times, is expected to close on July 17, 2025.

NAPLES, FL, July 14, 2025 (GLOBE NEWSWIRE) -- Music Licensing, Inc. (OTC: SONG) and its wholly owned subsidiary, Pro Music Rights, were recently featured in Bloomberg News and the Los Angeles Times in connection with national coverage on the rising costs and growing complexity of music licensing for restaurants and bars. The coverage highlights Pro Music Rights as a leading innovator among performance rights organizations (PROs), positioned to modernize an industry long dominated by legacy structures.

WARREN, N.J., July 14, 2025 (GLOBE NEWSWIRE) --  Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced that its artificial intelligence initiative, Tevogen.AI, in collaboration with Microsoft (Nasdaq: MSFT) and Databricks, has successfully built the alpha version of its foundational PredicTcell™ model.

SALT LAKE CITY, July 14, 2025 (GLOBE NEWSWIRE) -- Clarus Corporation (NASDAQ: CLAR) (“Clarus” and/or the “Company”), a global company focused on the outdoor enthusiast markets, has completed the Company’s previously announced sale of PIEPS and assets of the JetForce avalanche pack intellectual property to a private investment firm for a total purchase price of €7.8 million, or approximately $9.1 million, including cash and debt.

Payer coverage for Emrosi™ now available for 65% of commercial lives, up from 29% in May 2025

ROCKVILLE, Md. and SUZHOU, China, July 14, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International Inc. (NASDAQ: AAPG; HKEX: 6855) (“Ascentage” or the “Company”), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that Dajun Yang Dynasty Trust, an affiliate of the Company’s Chief Executive Officer, Dajun Yang, M.D., Ph.D. (the “Vendor”), proposes to offer ordinary shares, par value US$0.0001 per share, of the Company (the “Placement Shares”) in an offshore transaction outside the United States to non-U.S. persons in reliance on Regulation S under the Securities Act of 1933, as amended (the “Securities Act”), subject to market conditions and other factors (the “Offshore Placement”). At the time of the closing of the Offshore Placement, the Vendor would subscribe for, and the Company would issue to the Vendor new ordinary shares of the Company (the “Replacement Shares”) at the same number as the number of the Placement Shares offered in the Offshore Placement and at the same price per share as the price per share for the Placement Shares. The closing of the transaction involving the issuance of the Replacement Shares will be subject to customary closing conditions and take place after the closing of the Offshore Placement. In connection with the Offshore Placement, the representatives in the Company’s U.S. initial public offering in January 2025 waived a lock-up restriction with respect to the Placement Shares held by the Vendor.

The Hottest Country by Far

Saint Herblain (France), July, 11 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the European Medicines Agency (EMA) will lift the temporary restriction on vaccinating people aged 65 years and above after concluding a thorough review of Valneva’s single-dose chikungunya vaccine IXCHIQ^® by EMA’s safety committee (PRAC).